I Cell Disease is a rare genetic disorder that is inherited in an autosomal recessive manner. This means that both parents must carry a copy of the mutated gene for their child to be affected. The disease is caused by mutations in the GNPTAB gene, which leads to impaired enzyme function and affects the proper functioning of cells. Early diagnosis and management are crucial for individuals with I Cell Disease.
Is I Cell Disease hereditary?
I Cell Disease, also known as mucolipidosis type II, is a rare genetic disorder that is indeed hereditary. It is inherited in an autosomal recessive manner, which means that both parents must carry a copy of the mutated gene for their child to be affected.
The disease is caused by mutations in the GNPTAB gene, which provides instructions for producing an enzyme called N-acetylglucosamine-1-phosphotransferase. This enzyme is responsible for tagging certain proteins within cells, allowing them to be transported to the correct location. In individuals with I Cell Disease, the enzyme is either absent or not functioning properly, leading to the accumulation of undigested materials within the cells.
Since I Cell Disease is a genetic disorder, it can be passed down through generations. If both parents are carriers of the mutated gene, there is a 25% chance with each pregnancy that their child will inherit two copies of the mutated gene and develop the disease. There is a 50% chance that the child will be a carrier like the parents, and a 25% chance that the child will inherit two normal copies of the gene.
It is important for individuals with a family history of I Cell Disease to consult with a genetic counselor or healthcare professional for a comprehensive evaluation of their risk of passing on the disease to their children. Genetic testing can be performed to determine carrier status and provide information for family planning decisions.